Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act

Synopsis

Alvaiz (eltrombopag) tablets 2/06/26 3/06/26 Azurity Pharmaceuticals, Inc. Fanapt (iloperidone) tablets 10/01/20 11/13/20 Salix Pharmaceuticals, Inc.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.